MegaGen BeLux SRL
1.0 FTEMegaGen BeLux reported total assets of 100,159 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 1 full-time equivalent.
The score of MegaGen BeLux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Total assets +248 % Headcount (avg FTE) +25 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MegaGen BeLux's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
MegaGen BeLux's financial analysis
- Solvency-24.9%sector median: 33.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MegaGen BeLux
MegaGen BeLux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0793.466.136
- VAT number
- BE0793466136
- Peppol
- Registered · 0208:0793466136 · as of 12 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Nov 2022
- Registered office
- 1000 Brussels
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
MegaGen BeLux (SRL) has been based in Brussels since 2022, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 33,106 € and equity of −24,927 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -24.9%, below the median of its sector (33.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MegaGen BeLux
Companies in the same business, of comparable size and area, outside its group.
- A - Medica Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 105,140 €
- Feton Wholesale of pharmaceutical and medical goods Uccle · balance sheet 806,088 €
- Honeypatch Manufacture of pharmaceutical preparations Liège · balance sheet 330,409 €
- Roggen APO Wholesale of pharmaceutical and medical goods Dilbeek · balance sheet 68,518 €
- Stoma International Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet 65,737 €
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- RMS Evolution Wholesale of pharmaceutical and medical goods Roosdaal · balance sheet 164,586 €
- Added Pharma International Wholesale of pharmaceutical and medical goods Schoten · balance sheet 308,424 €
Frequently asked questions about MegaGen BeLux
What is the revenue of MegaGen BeLux?
MegaGen BeLux files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MegaGen BeLux?
In Belgium, the VAT number is the company number prefixed with BE: BE0793466136 for MegaGen BeLux, if the company is VAT-registered. Its company number (CBE) is 0793.466.136.
Where is the registered office of MegaGen BeLux?
According to the CBE register, the registered office of MegaGen BeLux is in 1000 Brussels.
What is the equity of MegaGen BeLux?
At the close of the 2025 financial year, the equity of MegaGen BeLux amounts to -24,927 €, a solvency of -24.9% of total assets.
How many people work at MegaGen BeLux?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages MegaGen BeLux?
The register lists 2 active mandates at MegaGen BeLux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MegaGen BeLux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →